心血管臨床試験市場：フェーズ、試験設計、適応症、最終用途、世界予測、2023～2032年

心血管臨床試験市場は、ライフスタイルに関連する要因や高齢化による心血管疾患の有病率の増加により、2023年から2032年にかけてCAGR 6.1%以上で成長すると予測されています。

世界心臓連盟の報告によると、心血管疾患による死亡者数は1990年の1,210万人から2021年には全世界で2,050万人に急増します。

さらに、医療技術の進歩と心血管系の健康に対する理解が、より洗練された的を絞った臨床試験の必要性を後押ししています。ウェアラブルデバイスや遠隔モニタリングなどの新たな技術は、データ収集を強化し、介入に対する患者の反応についてより包括的な理解を提供します。このような技術の進化は、臨床試験プロセスを合理化するだけでなく、心血管研究への投資を誘致しています。

心血管臨床試験産業は、フェーズ、試験設計、適応症、最終用途、地域に基づいてセグメント化されます。

肺動脈性肺高血圧症候群（PAHS）分野は、アンメットメディカルニーズの重要性と革新的な治療ソリューションに対する需要の高まりを背景に、2032年まで大幅な成長が見込まれています。肺動脈性肺高血圧症候群（PAHS）は、しばしば生命を脅かす深刻な課題であり、臨床試験を通じて効果的な治療法の開発に重点が置かれています。科学的知見と技術の進歩が標的治療への新たな道を提供する中、製薬企業は肺動脈性肺高血圧症候群（PAHS）の複雑な病態の解明に向けて努力を傾けています。

医療機器メーカーは、革新的な心血管技術の開発と試験において重要な役割を担っており、2023年から2032年にかけて大きなCAGRを記録すると予想されています。医療機器の進歩が心血管疾患の診断、モニタリング、治療に革命をもたらし続ける中、メーカーは自社製品の安全性と有効性を検証するために臨床試験に積極的に取り組んでいます。規制機関がエビデンスに基づく実践を重視するようになり、厳格な試験の必要性が高まっていることが、このセグメントの成長に有利に働くと思われます。

アジア太平洋の心血管臨床試験業界のシェアは、2023年から2032年にかけて大幅に成長すると予想されます。心血管疾患の蔓延は、標的を絞った介入への需要を増大させ、地域の健康上のニュアンスに焦点を当てた試験の好転につながっています。さらに、製薬企業、研究機関、政府機関の間の共同イニシアチブが勢いを増しており、地域の遺伝的とライフスタイルプロファイルの豊かな多様性を利用して心血管研究を推進し、地域市場の成長を後押ししています。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 循環器臨床試験市場洞察

• 業界情勢
• 業界への影響要因
  • 促進要因
    • 世界の心血管疾患の増加
    • 開発業務受託機関（CRO）の増加
    • 臨床試験に向けた研究開発費の増加
  • 業界の潜在的リスク・課題
    • 患者の確保と維持の課題
  • 成長可能性分析
  • フェーズ別
  • 試験デザイン別
  • 適応症別
  • 最終用途別
• COVID-19影響分析
• 規制状況
• ポーター分析
• PESTEL分析

第4章 競合情勢

• イントロダクション
• 企業マトリックス分析
• 主要市場参入企業の競合分析
• 競合のポジショニングマトリックス
• 戦略ダッシュボード

第5章 心血管臨床試験市場推定・予測：フェーズ別

• 主要動向：フェーズ別
• フェーズI
• フェーズII
• フェーズIII
• フェーズIV

第6章 心血管臨床試験市場推定・予測：試験設計別

• 主要動向：試験設計別
• 介入試験
• 観察研究
• 拡大アクセス

第7章 心血管臨床試験市場推定・予測：適応症別

• 主要動向：適応症別
• 脳血管疾患
• 冠動脈疾患
• 高血圧性心疾患
• 心臓不整脈
• 炎症性心疾患
• 肺動脈性肺高血圧症候群（PAHS）
• 虚血性心疾患
• 心不全
• その他の適応症

第8章 心血管臨床試験市場推定・予測：最終用途別

• 主要動向：最終用途別
• バイオテクノロジーと製薬企業
• 医療機器メーカー
• 開発業務受託機関（CRO）
• その他のエンドユーザー

第9章 心血管臨床試験市場推定・予測：地域別

• 主要動向：地域別
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他の欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • オーストラリア
  • その他のアジア太平洋
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他のラテンアメリカ
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • その他の中東とアフリカ

第10章 企業プロファイル

• Eli Lilly & Company
• IQVIA Inc
• Worldwide Clinical Trials
• ICON plc
• Thermo Fisher Scientific（PPD Inc）
• Syneos Health
• Medpace, Inc.
• Veeda Clinical Research
• WuXi AppTech
• Pfizer
• Merck & Co

Data Tables

• TABLE 1 Market revenue, by phase (2022)
• TABLE 2 Market revenue, by study design (2022)
• TABLE 3 Market revenue, by indication (2022)
• TABLE 4 Market revenue, by end-use (2022)
• TABLE 5 Market share, by region (2022)
• TABLE 6 Global cardiovascular clinical trials market size, by region, 2018 - 2022 (USD Million)
• TABLE 7 Global cardiovascular clinical trials market size, by region, 2023 - 2032 (USD Million)
• TABLE 8 Global cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
• TABLE 9 Global cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
• TABLE 10 Global cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
• TABLE 11 Global cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
• TABLE 12 Global cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
• TABLE 13 Global cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
• TABLE 14 Global cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 15 Global cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 16 Industry impact forces
• TABLE 17 Phase I market size, 2018 - 2022 (USD Million)
• TABLE 18 Phase I market size, 2023 - 2032 (USD Million)
• TABLE 19 Phase II market size, 2018 - 2022 (USD Million)
• TABLE 20 Phase II market size, 2023 - 2032 (USD Million)
• TABLE 21 Phase III market size, 2018 - 2022 (USD Million)
• TABLE 22 Phase III market size, 2023 - 2032 (USD Million
• TABLE 23 Phase IV market size, 2018 - 2022 (USD Million)
• TABLE 24 Phase IV market size, 2023 - 2032 (USD Million
• TABLE 25 Interventional market size, 2018 - 2022 (USD Million)
• TABLE 26 Interventional market size, 2023 - 2032 (USD Million
• TABLE 27 Observational market size, 2018 - 2022 (USD Million)
• TABLE 28 Observational market size, 2023 - 2032 (USD Million
• TABLE 29 Expanded access market size, 2018 - 2022 (USD Million)
• TABLE 30 Expanded access market size, 2023 - 2032 (USD Million)
• TABLE 31 Cerebrovascular disease market size, 2018 - 2022 (USD Million)
• TABLE 32 Cerebrovascular disease market size, 2023 - 2032 (USD Million)
• TABLE 33 Coronary artery disease market size, 2018 - 2022 (USD Million)
• TABLE 34 Coronary artery disease market size, 2023 - 2032 (USD Million)
• TABLE 35 Hypertensive heart disease market size, 2018 - 2022 (USD Million)
• TABLE 36 Hypertensive heart disease market size, 2023 - 2032 (USD Million)
• TABLE 37 Cardiac arrhythmia market size, 2018 - 2022 (USD Million)
• TABLE 38 Cardiac arrhythmia market size, 2023 - 2032 (USD Million)
• TABLE 39 Inflammatory heart disease market size, 2018 - 2022 (USD Million)
• TABLE 40 Inflammatory heart disease market size, 2023 - 2032 (USD Million)
• TABLE 41 Pulmonary arterial hypertension syndrome market size, 2018 - 2022 (USD Million)
• TABLE 42 Pulmonary arterial hypertension syndrome market size, 2023 - 2032 (USD Million)
• TABLE 43 Ischemic heart disease market size, 2018 - 2022 (USD Million)
• TABLE 44 Ischemic heart disease market size, 2023 - 2032 (USD Million)
• TABLE 45 Heart failure market size, 2018 - 2022 (USD Million)
• TABLE 46 Heart failure market size, 2023 - 2032 (USD Million)
• TABLE 47 Stroke market size, 2018 - 2022 (USD Million)
• TABLE 48 Stroke market size, 2023 - 2032 (USD Million)
• TABLE 49 Other indications market size, 2018 - 2022 (USD Million)
• TABLE 50 Other indications market size, 2023 - 2032 (USD Million)
• TABLE 51 Biotechnology and pharmaceutical companies market size, 2018 - 2022 (USD Million)
• TABLE 52 Biotechnology and pharmaceutical companies market size, 2023 - 2032 (USD Million)
• TABLE 53 Medical device manufacturers market size, 2018 - 2022 (USD Million)
• TABLE 54 Medical device manufacturers market size, 2023 - 2032 (USD Million)
• TABLE 55 Contract research organization (CRO) market size, 2018 - 2022 (USD Million)
• TABLE 56 Contract research organization (CRO) size, 2023 - 2032 (USD Million)
• TABLE 57 Other end-users market size, 2018 - 2022 (USD Million)
• TABLE 58 Other end-users market size, 2023 - 2032 (USD Million)
• TABLE 59 North America cardiovascular clinical trials market size, by country, 2018 - 2022 (USD Million)
• TABLE 60 North America cardiovascular clinical trials market size, by country, 2023 - 2032 (USD Million)
• TABLE 61 North America cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
• TABLE 62 North America cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
• TABLE 63 North America cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
• TABLE 64 North America cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
• TABLE 65 North America cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
• TABLE 66 North America cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
• TABLE 67 North America cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 68 North America cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 69 U.S. cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
• TABLE 70 U.S. cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
• TABLE 71 U.S. cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
• TABLE 72 U.S. cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
• TABLE 73 U.S. cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
• TABLE 74 U.S. cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
• TABLE 75 U.S. cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 76 U.S. cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 77 Canada cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
• TABLE 78 Canada cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
• TABLE 79 Canada cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
• TABLE 80 Canada cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
• TABLE 81 Canada cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
• TABLE 82 Canada cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
• TABLE 83 Canada cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 84 Canada cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 85 Europe cardiovascular clinical trials market size, by country, 2018 - 2022 (USD Million)
• TABLE 86 Europe cardiovascular clinical trials market size, by country, 2023 - 2032 (USD Million)
• TABLE 87 Europe cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
• TABLE 88 Europe cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
• TABLE 89 Europe cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
• TABLE 90 Europe cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
• TABLE 91 Europe cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
• TABLE 92 Europe cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
• TABLE 93 Europe cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 94 Europe cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 95 Germany cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
• TABLE 96 Germany cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
• TABLE 97 Germany cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
• TABLE 98 Germany cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
• TABLE 99 Germany cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
• TABLE 100 Germany cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
• TABLE 101 Germany cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 102 Germany cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 103 UK cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
• TABLE 104 UK cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
• TABLE 105 UK cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
• TABLE 106 UK cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
• TABLE 107 UK cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
• TABLE 108 UK cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
• TABLE 109 UK cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 110 UK cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 111 France cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
• TABLE 112 France cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
• TABLE 113 France cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
• TABLE 114 France cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
• TABLE 115 France cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
• TABLE 116 France cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
• TABLE 117 France cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 118 France cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 119 Spain cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
• TABLE 120 Spain cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
• TABLE 121 Spain cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
• TABLE 122 Spain cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
• TABLE 123 Spain cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
• TABLE 124 Spain cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
• TABLE 125 Spain cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 126 Spain cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 127 Italy cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
• TABLE 128 Italy cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
• TABLE 129 Italy cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
• TABLE 130 Italy cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
• TABLE 131 Italy cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
• TABLE 132 Italy cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
• TABLE 133 Italy cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 134 Italy cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 135 Rest of Europe cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
• TABLE 136 Rest of Europe cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
• TABLE 137 Rest of Europe cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
• TABLE 138 Rest of Europe cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
• TABLE 139 Rest of Europe cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
• TABLE 140 Rest of Europe cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
• TABLE 141 Rest of Europe cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 142 Rest of Europe cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 143 Asia Pacific cardiovascular clinical trials market size, by country, 2018 - 2022 (USD Million)
• TABLE 144 Asia Pacific cardiovascular clinical trials market size, by country, 2023 - 2032 (USD Million)
• TABLE 145 Asia Pacific cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
• TABLE 146 Asia Pacific cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
• TABLE 147 Asia Pacific cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
• TABLE 148 Asia Pacific cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
• TABLE 149 Asia Pacific cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
• TABLE 150 Asia Pacific cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
• TABLE 151 Asia Pacific cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 152 Asia Pacific cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 153 China cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
• TABLE 154 China cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
• TABLE 155 China cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
• TABLE 156 China cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
• TABLE 157 China cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
• TABLE 158 China cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
• TABLE 159 China cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 160 China cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 161 Japan cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
• TABLE 162 Japan cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
• TABLE 163 Japan cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
• TABLE 164 Japan cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
• TABLE 165 Japan cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
• TABLE 166 Japan cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
• TABLE 167 Japan cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 168 Japan cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 169 India cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
• TABLE 170 India cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
• TABLE 171 India cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
• TABLE 172 India cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
• TABLE 173 India cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
• TABLE 174 India cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
• TABLE 175 India cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 176 India cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 177 Australia cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
• TABLE 178 Australia cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
• TABLE 179 Australia cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
• TABLE 180 Australia cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
• TABLE 181 Australia cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
• TABLE 182 Australia cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
• TABLE 183 Australia cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 184 Australia cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 185 Rest of Asia Pacific cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
• TABLE 186 Rest of Asia Pacific cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
• TABLE 187 Rest of Asia Pacific cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
• TABLE 188 Rest of Asia Pacific cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
• TABLE 189 Rest of Asia Pacific cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
• TABLE 190 Rest of Asia Pacific cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
• TABLE 191 Rest of Asia Pacific cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 192 Rest of Asia Pacific cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 193 Latin America cardiovascular clinical trials market size, by country, 2018 - 2022 (USD Million)
• TABLE 194 Latin America cardiovascular clinical trials market size, by country, 2023 - 2032 (USD Million)
• TABLE 195 Latin America cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
• TABLE 196 Latin America cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
• TABLE 197 Latin America cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
• TABLE 198 Latin America cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
• TABLE 199 Latin America cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
• TABLE 200 Latin America cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
• TABLE 201 Latin America cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 202 Latin America cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 203 Brazil cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
• TABLE 204 Brazil cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
• TABLE 205 Brazil cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
• TABLE 206 Brazil cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
• TABLE 207 Brazil cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
• TABLE 208 Brazil cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
• TABLE 209 Brazil cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 210 Brazil cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 211 Mexico cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
• TABLE 212 Mexico cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
• TABLE 213 Mexico cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
• TABLE 214 Mexico cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
• TABLE 215 Mexico cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
• TABLE 216 Mexico cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
• TABLE 217 Mexico cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 218 Mexico cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 219 Rest of Latin America cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
• TABLE 220 Rest of Latin America cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
• TABLE 221 Rest of Latin America cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
• TABLE 222 Rest of Latin America cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
• TABLE 223 Rest of Latin America cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
• TABLE 224 Rest of Latin America cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
• TABLE 225 Rest of Latin America cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 226 Rest of Latin America cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 227 Middle East & Africa cardiovascular clinical trials market size, by country, 2018 - 2022 (USD Million)
• TABLE 228 Middle East & Africa cardiovascular clinical trials market size, by country, 2023 - 2032 (USD Million)
• TABLE 229 Middle East & Africa cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
• TABLE 230 Middle East & Africa cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
• TABLE 231 Middle East & Africa cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
• TABLE 232 Middle East & Africa cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
• TABLE 233 Middle East & Africa cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
• TABLE 234 Middle East & Africa cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
• TABLE 235 Middle East & Africa cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 236 Middle East & Africa cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 237 South Africa cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
• TABLE 238 South Africa cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
• TABLE 239 South Africa cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
• TABLE 240 South Africa cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
• TABLE 241 South Africa cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
• TABLE 242 South Africa cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
• TABLE 243 South Africa cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 244 South Africa cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 245 Saudi Arabia cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
• TABLE 246 Saudi Arabia cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
• TABLE 247 Saudi Arabia cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
• TABLE 248 Saudi Arabia cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
• TABLE 249 Saudi Arabia cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
• TABLE 250 Saudi Arabia cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
• TABLE 251 Saudi Arabia cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 252 Saudi Arabia cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 253 Rest of Middle East & Africa cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
• TABLE 254 Rest of Middle East & Africa cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
• TABLE 255 Rest of Middle East & Africa cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
• TABLE 256 Rest of Middle East & Africa cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
• TABLE 257 Rest of Middle East & Africa cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
• TABLE 258 Rest of Middle East & Africa cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
• TABLE 259 Rest of Middle East & Africa cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 260 Rest of Middle East & Africa cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)

Charts & Figures

• FIG 1 GMI report coverage: critical research elements
• FIG 2 Top-down approach
• FIG 3 Market estimation and forecast methodology
• FIG 4 Market forecasting methodology
• FIG 5 Breakdown of primary participants
• FIG 6 Cardiovascular clinical trials market industry 360 degree synopsis, 2018 - 2032
• FIG 7 Growth potential analysis, by phase
• FIG 8 Growth potential analysis, by study design
• FIG 9 Growth potential analysis, by indication
• FIG 10 Growth potential analysis, by end-use
• FIG 11 Porter's analysis
• FIG 12 PESTEL analysis
• FIG 13 Company matrix analysis, 2022
• FIG 14 Competitive analysis of major market players, 2022
• FIG 15 Competitive positioning matrix, 2022
• FIG 16 Strategic dashboard, 2022

Cardiovascular Clinical Trials Market is projected to grow at a CAGR of over 6.1% over 2023-2032, owing to the increasing prevalence of cardiovascular diseases due to lifestyle related factors and aging population. As per the reports from World Heart Federation, the cardiovascular deaths surged from 12.1 million in 1990 to 20.5 million across the globe in 2021.

Additionally, advancements in medical technology and the understanding of cardiovascular health have propelled the need for more sophisticated and targeted clinical trials. Emerging technologies, such as wearable devices and remote monitoring, enhance data collection and provide a more comprehensive understanding of patient responses to interventions. This technological evolution not only streamlines trial processes but also attracts investment in cardiovascular research.

Cardiovascular clinical trials industry is segmented based on phase, study design, indication, end-use, and region.

Pulmonary arterial hypertension syndrome (PAHS) segment is anticipated to witness substantial growth through 2032, backed by critical unmet medical needs and the rising demand for innovative therapeutic solutions. PAHS poses a severe and often life-threatening challenge, prompting increased focus on developing effective treatments through clinical trials. As advancements in scientific insight and technology provide new avenues for targeted therapies, pharmaceutical companies are directing their efforts toward unraveling the complexities of pulmonary arterial hypertension.

Medical devices manufacturers segment is anticipated to observe a significant CAGR during 2023 and 2032, favored by its vital role in developing and testing innovative cardiovascular technologies. As advancements in medical devices continue to revolutionize the diagnosis, monitoring, and treatment of cardiovascular conditions, manufacturers are actively engaged in clinical trials to validate the safety and efficacy of their products. Regulatory bodies' increasing emphasis on evidence-based practices and the need for rigorous testing will favor the segment growth.

Asia Pacific cardiovascular clinical trials industry share will grow substantially between 2023 and 2032, attributed to the evolving healthcare infrastructure, coupled with an expanding patient pool. The prevalence of cardiovascular diseases amplifies the demand for targeted interventions, leading to a turnaround in trials focused on regional health nuances. Furthermore, collaborative initiatives between pharmaceutical companies, research institutions, and government bodies are gaining momentum, harnessing the rich diversity in the region's genetic and lifestyle profiles to advance cardiovascular research, pushing the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definition
• 1.2 Base estimates & calculations
• 1.3 Forecast Calculation
• 1.4 COVID-19 impact analysis at global level
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Cardiovascular clinical trials industry 360 degree synopsis, 2018 - 2032 (USD Million)
  • 2.1.1 Business trends
  • 2.1.2 Regional trends
  • 2.1.3 Phase trends
  • 2.1.4 Study design trends
  • 2.1.5 Indication trends
  • 2.1.6 End-use trends

Chapter 3 Cardiovascular Clinical Trials Market Insights

• 3.1 Industry landscape, 2018 - 2032 (USD Million)
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising burden of cardiovascular diseases globally
    • 3.2.1.2 Increasing number of contract research organizations (CROs)
    • 3.2.1.3 Increasing R&D expenditure towards clinical trials
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Patient recruitment and retention challenges
  • 3.2.3 Growth potential analysis
  • 3.2.4 By phase
  • 3.2.5 By study design
  • 3.2.6 By indication
  • 3.2.7 By end use
• 3.3 COVID-19 impact analysis
• 3.4 Regulatory landscape
• 3.5 Porter's analysis
• 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Competitive analysis of major market players, 2022
• 4.4 Competitive positioning matrix, 2022
• 4.5 Strategic dashboard, 2022

Chapter 5 Cardiovascular Clinical Trials Market Estimates and Forecast, By Phase, 2018-2032 (USD Million)

• 5.1 Key trends, by phase
• 5.2 Phase I
• 5.3 Phase II
• 5.4 Phase III
• 5.5 Phase IV

Chapter 6 Cardiovascular Clinical Trials Market Estimates and Forecast, By Study Design, 2018-2032 (USD Million)

• 6.1 Key trends, by study design
• 6.2 Interventional
• 6.3 Observational
• 6.4 Expanded access

Chapter 7 Cardiovascular Clinical Trials Market Estimates and Forecast, By Indication, 2018-2032 (USD Million)

• 7.1 Key trends, by indication
• 7.2 Cerebrovascular disease
• 7.3 Coronary artery disease
• 7.4 Hypertensive heart disease
• 7.5 Cardiac arrhythmia
• 7.6 Inflammatory heart disease
• 7.7 Pulmonary arterial hypertension syndrome
• 7.8 Ischemic heart disease
• 7.9 Heart failure
• 7.10 Other indications

Chapter 8 Cardiovascular Clinical Trials Market Estimates and Forecast, By End Use, 2018-2032 (USD Million)

• 8.1 Key trends, by end-use
• 8.2 Biotechnology and pharmaceutical companies
• 8.3 Medical devices manufacturers
• 8.4 Contract research organization (CRO)
• 8.5 Other end users

Chapter 9 Cardiovascular Clinical Trials Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

• 9.1 Key trends, by region
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Rest of Latin America
• 9.6 Middle East & Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 Rest of Middle East & Africa

Chapter 10 Company Profiles

• 10.1 Eli Lilly & Company
• 10.2 IQVIA Inc
• 10.3 Worldwide Clinical Trials
• 10.4 ICON plc
• 10.5 Thermo Fisher Scientific (PPD Inc)
• 10.6 Syneos Health
• 10.7 Medpace, Inc.
• 10.8 Veeda Clinical Research
• 10.9 WuXi AppTech
• 10.10 Pfizer
• 10.11 Merck & Co